Cortigent, Inc. (CRGT)

Cortigent Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Cost of Revenue	0	0	0.13
Gross Profit	0	0	0.13
Selling, General & Admin	6.25	6.25	6.32
Research & Development	2.45	2.45	2.37
Other Operating Expenses	0.73	0.73	0.38
Operating Expenses	9.43	9.43	9.06
Operating Income	-9.43	-9.43	-8.93
Interest Expense / Income	-0.83	-0.83	-0.01
Pretax Income	-8.6	-8.6	-8.92
Net Income	-8.6	-8.6	-8.92
Free Cash Flow	-9.82	-9.82	-9.2
EBITDA	-9.36	-9.36	-8.86
Depreciation & Amortization	0.06	0.06	0.07
EBIT	-9.43	-9.43	-8.93

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).